Antonio Gasbarrini to Disease Progression
This is a "connection" page, showing publications Antonio Gasbarrini has written about Disease Progression.
Connection Strength
0.183
-
Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study. Hepatology. 2018 10; 68(4):1232-1244.
Score: 0.048
-
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The "EPIMICI - San Marino" study. Dig Liver Dis. 2019 02; 51(2):218-225.
Score: 0.048
-
"Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial". Trials. 2020 Oct 22; 21(1):875.
Score: 0.014
-
Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis. Dig Liver Dis. 2020 12; 52(12):1383-1389.
Score: 0.014
-
Evaluation of the lung microbiome as a therapeutic target in the management of idiopathic pulmonary fibrosis: role of antioxidant/antibiotic combination therapy. Eur Rev Med Pharmacol Sci. 2019 Jul; 23(14):6379-6386.
Score: 0.013
-
Real life experiences in HCV management in 2018. Expert Rev Anti Infect Ther. 2019 02; 17(2):117-128.
Score: 0.012
-
ToF-SIMS and principal component analysis of lipids and amino acids from inflamed and dysplastic human colonic mucosa. Anal Bioanal Chem. 2017 Oct; 409(26):6097-6111.
Score: 0.011
-
Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach. World J Gastroenterol. 2017 May 14; 23(18):3195-3204.
Score: 0.011
-
Primary Biliary Cholangitis: advances in management and treatment of the disease. Dig Liver Dis. 2017 Aug; 49(8):841-846.
Score: 0.011